Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;26(5):e14235.
doi: 10.1111/petr.14235. Epub 2022 Jan 20.

Update on COVID-19 vaccination in pediatric solid organ transplant recipients

Affiliations
Review

Update on COVID-19 vaccination in pediatric solid organ transplant recipients

Daniel E Dulek et al. Pediatr Transplant. 2022 Aug.

Abstract

Background: COVID-19 vaccination has been successful in decreasing rates of SARS-CoV-2 infection in areas with high vaccine uptake. Cases of breakthrough SARS-CoV-2 infection remain infrequent among immunocompetent vaccine recipients who are protected from severe COVID-19. Robust data demonstrate the safety, immunogenicity, and effectiveness of several COVID-19 vaccine formulations. Importantly, Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine studies have now included children as young as 5 years of age with safety, immunogenicity, and effectiveness data publicly available. In the United States, emergency use authorization by the Federal Drug Administration and approval from the Centers for Disease Control/Advisory Committee on Immunization Practices have been provided for the 5- to 11-year-old age group.

Methods: Members of the International Pediatric Transplant Association (IPTA) provide an updated review of current COVID-19 vaccine data with focus on pediatric solid organ transplant (SOT)-specific issues.

Results: This review provides an overview of current COVID-19 immunogenicity, safety, and efficacy data from key studies, with focus on data of importance to pediatric SOT recipients. Continued paucity of data in the setting of pediatric transplantation remains a challenge.

Conclusions: Further studies of COVID-19 vaccination in pediatric SOT recipients are needed to better understand post-vaccine COVID-19 T-cell and antibody kinetics and determine the optimal vaccine schedule. Increased COVID-19 vaccine acceptability, uptake, and worldwide availability are needed to limit the risk that COVID-19 poses to pediatric solid organ transplant recipients.

Keywords: COVID-19; SARS-CoV-2; children; immunization; solid organ transplantation; vaccination; vaccine.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Siegel DA, Reses HE, Cool AJ, et al. Trends in COVID-19 cases, emergency department visits, and hospital admissions among children and adolescents aged 0-17 years - United States, august 2020-august 2021. MMWR Morb Mortal Wkly Rep. 2021;70(36):1249-1254.
    1. Delahoy MJ, Ujamaa D, Whitaker M, et al. Hospitalizations associated with COVID-19 among children and adolescents - COVID-NET, 14 States, march 1, 2020-august 14, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(36):1255-1260.
    1. American Academy of Pediatrics (AAP). Children and COVID-19: state-level data report. September 9, 2021. Available at: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/.... Accessed September 18, 2021.
    1. Center for Disease Control and Prevention. National center for health statistics. weekly updates by select demographic and geographic characteristics. Available at: https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm#SexAndAge. Accessed September 18, 2021.
    1. Riffe T, Acosta E. Team TC-D. Data resource profile: COVerAGE-DB: a global demographic database of COVID-19 cases and deaths. Int J Epidemiol. 2021;50(2):390-f.

LinkOut - more resources